Oral mucormycosis in post-COVID-19 patients: A case series

The rise of mucormycosis in COVID-19 patients is predisposed by indiscriminate intake of corticosteroids, poorly controlled diabetes, injury, the prolonged neutropenia, organ transplant, hemopoietic malignancies, prolonged stays in the intensive care unit and due to nosocomial infection (Raut &Huy, 2021).Oral lesions seen in COVID-19 patients are more probably caused by co-infections, adverse reactions, immunocompromised conditions instead of direct COVID-19 infection. Not every mucormycosis that occurs in the pandemic times is due to COVID-19.We would like to report 4 post-COVID-19 patients who had oral mucormycosis after covid recovery period.

• Publication year

  2022

• Venue

  Indian Journal of Case Reports

• Publication date

  2022-03-21

• Fields of study

  Not labeled

• Identifiers
  DOI 10.32677/ijcr.v8i2.3258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral mucormycosis in post‐COVID‐19 patients: A case series

  2021cited by this paper
• The rise of mucormycosis in Covid-19 patients in India

  2021influential reference
• Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19

  2021cited by this paper
• COVID-19 associated rhinosinusitis mucormycosis due to Rhizopus arrhizus: A rare but potentially fatal infection occurring after treatment with corticosteroids

  2021cited by this paper
• High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections

  2021cited by this paper
• ECMM/MSG –ERC

  2019cited by this paper
• Mucormycosis in a Diabetic Patient: A Case Report with an Insight into Its Pathophysiology

  2017cited by this paper
• Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox: A Case Report

  2014cited by this paper
• Mucormycosis--from the pathogens to the disease.

  2014cited by this paper
• Clinical Features and Outcome of Mucormycosis

  2014cited by this paper
• Epidemiology and clinical manifestations of mucormycosis.

  2012cited by this paper
• Pathogenesis of mucormycosis.

  2012cited by this paper
• Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

  2005cited by this paper

• Maxillary mucormycosis masquerading as an endodontic-periodontal lesion

  2024cites this paper